ALLIANCEBERNSTEIN L.P. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 3 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$4,239,000
+140.4%
182,411
+64.7%
0.00%
+200.0%
Q1 2018$1,763,000
-62.6%
110,743
-51.2%
0.00%
-66.7%
Q4 2017$4,716,000
+751.3%
226,958
+487.0%
0.00%
Q3 2017$554,000
-78.4%
38,661
-73.9%
0.00%
-100.0%
Q2 2017$2,560,000
+485.8%
147,990
+273.1%
0.00%
Q1 2017$437,000
+13.2%
39,664
+49.3%
0.00%
Q4 2016$386,000
-52.9%
26,572
-20.4%
0.00%
-100.0%
Q3 2016$820,000
+32.0%
33,389
+8.3%
0.00%0.0%
Q2 2016$621,000
-72.1%
30,828
-63.5%
0.00%
-50.0%
Q1 2016$2,222,000
-93.4%
84,474
-74.4%
0.00%
-93.1%
Q4 2015$33,577,000
+228.7%
330,321
+476.9%
0.03%
+222.2%
Q3 2015$10,214,000
-37.0%
57,260
-21.5%
0.01%
-30.8%
Q2 2015$16,201,000
+69.0%
72,926
+50.3%
0.01%
+62.5%
Q1 2015$9,584,000
-22.0%
48,511
-43.3%
0.01%
-20.0%
Q4 2014$12,293,000
+115.4%
85,602
+97.0%
0.01%
+100.0%
Q3 2014$5,706,000
-69.8%
43,450
-71.0%
0.01%
-68.8%
Q2 2014$18,910,000
+229.6%
149,939
+244.4%
0.02%
+220.0%
Q1 2014$5,737,000
+3.9%
43,542
-7.5%
0.01%0.0%
Q4 2013$5,520,000
+13.6%
47,061
+1.2%
0.01%0.0%
Q3 2013$4,858,000
+15.7%
46,495
-4.8%
0.01%
+25.0%
Q2 2013$4,199,00048,8500.00%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2018
NameSharesValueWeighting ↓
Bruce & Co., Inc. 550,000$3,833,5001.26%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders